---
title: "HANMA TECHNOLOGY: The net profit for the third quarter was 12.9044 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263059038.md"
description: "HANMA TECHNOLOGY announced that its revenue for the third quarter was 1.607 billion yuan, a year-on-year increase of 35.74%; net profit was 12.9044 million yuan. Revenue for the first three quarters was 4.455 billion yuan, a year-on-year increase of 44.54%; net profit was 40.6326 million yuan"
datetime: "2025-10-28T10:32:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263059038.md)
  - [en](https://longbridge.com/en/news/263059038.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263059038.md)
---

# HANMA TECHNOLOGY: The net profit for the third quarter was 12.9044 million yuan

HANMA TECHNOLOGY announced that its revenue for the third quarter was 1.607 billion yuan, a year-on-year increase of 35.74%; net profit was 12.9044 million yuan. Revenue for the first three quarters was 4.455 billion yuan, a year-on-year increase of 44.54%; net profit was 40.6326 million yuan

### Related Stocks

- [600375.CN](https://longbridge.com/en/quote/600375.CN.md)

## Related News & Research

- [09:06 ETHarmony Comes to the Massachusetts State House as The Platters® Prepare Their Musical Love Letter to the World](https://longbridge.com/en/news/286918739.md)
- [Strix Discloses Trust-Led Share Tender by Non-Executive Director](https://longbridge.com/en/news/286884952.md)
- [Elon Musk's X admits noncompliance with Australia child protection request](https://longbridge.com/en/news/287130082.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [RITFIT Partners with LA Galaxy's Marco Reus, Redefining High Quality Training at Home and Showcasing the Evolution of Professional Home Gym Ecosystems](https://longbridge.com/en/news/287232960.md)